APA (7th ed.) Citation

R, F., M, B., YC, L., S, P., K, R., R, M., & M, S. (2022). Clinical Trial Protocol for HyNOVA: Hyperthermic and Normothermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III epithelial OVArian, fallopian tube and primary peritoneal cancer (ANZGOG1901/2020). Journal of gynecologic oncology, 33(1), e1. https://doi.org/10.3802/jgo.2022.33.e1

Chicago Style (17th ed.) Citation

R, Farrell, Burling M, Lee YC, Pather S, Robledo K, Mercieca-Bebber R, and Stockler M. "Clinical Trial Protocol for HyNOVA: Hyperthermic and Normothermic Intraperitoneal Chemotherapy Following Interval Cytoreductive Surgery for Stage III Epithelial OVArian, Fallopian Tube and Primary Peritoneal Cancer (ANZGOG1901/2020)." Journal of Gynecologic Oncology 33, no. 1 (2022): e1. https://doi.org/10.3802/jgo.2022.33.e1.

MLA (9th ed.) Citation

R, Farrell, et al. "Clinical Trial Protocol for HyNOVA: Hyperthermic and Normothermic Intraperitoneal Chemotherapy Following Interval Cytoreductive Surgery for Stage III Epithelial OVArian, Fallopian Tube and Primary Peritoneal Cancer (ANZGOG1901/2020)." Journal of Gynecologic Oncology, vol. 33, no. 1, 2022, p. e1, https://doi.org/10.3802/jgo.2022.33.e1.